Sleep and Circadian Rhythms in Mechanically Ventilated Patients
Primary Purpose
Respiratory Failure, Critical Illness
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Environmental modification
Sponsored by
About this trial
This is an interventional other trial for Respiratory Failure focused on measuring Polysomnography, Circadian rhythmicity
Eligibility Criteria
Inclusion Criteria:
- Adults undergoing mechanical ventilation in the medical intensive care unit.
Exclusion Criteria:
- Central nervous system disease (stroke, seizure, dementia, etc)
- Metabolic or hypoxic encephalopathy
- Confirmed or suspected drug overdose
- Currently receiving neuromuscular blockers
- Coma
Sites / Locations
- University of Chicago
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
No Intervention
No Intervention
Arm Label
Environmental modification
Usual care (randomized)
Usual care (observational)
Arm Description
Subjects assigned to this group receive the environmental modification intervention for 48 hours beginning the morning after enrollment.
Usual care is provided for the first 48 hours. Subsequently, in the initial protocol, subjects received 48 hours of the environmental modification intervention so long as they remained in the ICU during this time. The opportunity to receive the "Delayed" intervention was later removed from the protocol.
Usual care was provided.
Outcomes
Primary Outcome Measures
Percentage of Subjects Who Successfully Undergo Continuous Bedside Polysomnography for at Least 24 Hours.
This study assesses the feasibility of studying sleep and circadian rhythmicity in acutely ill, mechanically ventilated patients through the application of continuous bedside polysomnography. Feasibility will be assessed by determining the percentage of enrolled subjects who undergo at least 24 hours of continuous bedside polysomnography.
Secondary Outcome Measures
Subject Tolerance of the Environmental Modification Protocol
This outcome measure will examine, in a preliminary fashion, subject tolerance of the environmental modification protocol. Tolerance will be assessed through qualitative interviews performed by the PI with the subjects.
Full Information
NCT ID
NCT01276652
First Posted
January 10, 2011
Last Updated
July 25, 2017
Sponsor
University of Iowa
Collaborators
National Heart, Lung, and Blood Institute (NHLBI), The Brain Research Foundation, University of Chicago
1. Study Identification
Unique Protocol Identification Number
NCT01276652
Brief Title
Sleep and Circadian Rhythms in Mechanically Ventilated Patients
Official Title
Sleep and Circadian Rhythms in Mechanically Ventilated Patients: a Feasibility and Mechanistic Study.
Study Type
Interventional
2. Study Status
Record Verification Date
July 2017
Overall Recruitment Status
Completed
Study Start Date
November 2001 (undefined)
Primary Completion Date
December 2008 (Actual)
Study Completion Date
December 2008 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Iowa
Collaborators
National Heart, Lung, and Blood Institute (NHLBI), The Brain Research Foundation, University of Chicago
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This study examines the feasibility of assessing sleep and circadian rhythmicity in critically ill patients undergoing mechanical ventilation. Secondarily, it will examine the feasibility of reducing subject exposure to environmental light and noise and of delivering routine care according to classical day/night routines.
Detailed Description
Over 1 million patients develop respiratory failure annually in the United States; yet, the sleep of patients undergoing mechanical ventilation has received little attention. This protocol enrolls acutely ill medical patients undergoing mechanical ventilation. The feasibility of assessing sleep and circadian rhythmicity through the use of continuous bedside polysomnography and the measurement of core body temperature and urinary hormonal levels at frequent intervals will be explored. As a secondary goal, the feasibility of delivering routine care according to classical day/night routines, and of employing various noise and light reduction strategies at night, will be explored in a subset of subjects.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Respiratory Failure, Critical Illness
Keywords
Polysomnography, Circadian rhythmicity
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Subjects were randomized in 1:1 fashion to receive the Environmental Modification protocol or usual care. Subsequently a third, observational arm was opened to acquire more physiologic data.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
25 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Environmental modification
Arm Type
Active Comparator
Arm Description
Subjects assigned to this group receive the environmental modification intervention for 48 hours beginning the morning after enrollment.
Arm Title
Usual care (randomized)
Arm Type
No Intervention
Arm Description
Usual care is provided for the first 48 hours. Subsequently, in the initial protocol, subjects received 48 hours of the environmental modification intervention so long as they remained in the ICU during this time. The opportunity to receive the "Delayed" intervention was later removed from the protocol.
Arm Title
Usual care (observational)
Arm Type
No Intervention
Arm Description
Usual care was provided.
Intervention Type
Behavioral
Intervention Name(s)
Environmental modification
Intervention Description
Environmental modification consists of nursing-related efforts to optimize daytime light exposure, to minimize nighttime light and noise exposure, and to batch nursing care at night.
Primary Outcome Measure Information:
Title
Percentage of Subjects Who Successfully Undergo Continuous Bedside Polysomnography for at Least 24 Hours.
Description
This study assesses the feasibility of studying sleep and circadian rhythmicity in acutely ill, mechanically ventilated patients through the application of continuous bedside polysomnography. Feasibility will be assessed by determining the percentage of enrolled subjects who undergo at least 24 hours of continuous bedside polysomnography.
Time Frame
Average 4 days (patients followed to hospital discharge)
Secondary Outcome Measure Information:
Title
Subject Tolerance of the Environmental Modification Protocol
Description
This outcome measure will examine, in a preliminary fashion, subject tolerance of the environmental modification protocol. Tolerance will be assessed through qualitative interviews performed by the PI with the subjects.
Time Frame
Average 4 days (patients followed to hospital discharge)
Other Pre-specified Outcome Measures:
Title
Occurrence of REM Sleep
Description
Occurrence of identifiable rapid eye movement (REM) sleep in each subject.
Time Frame
Average 4 days (patients followed to hospital discharge)
Title
Normal Timing of 6-sulfatoxymelatonin Excretion
Description
The number of participants in each group who exhibit normal timing of 6-sulfatoxymelatonin excretion will be reported. The normal timing of peak melatonin excretion was considered to be between midnight and 05:00. Subjects in whom the melatonin onset occurred after midnight or the acrophase occurred after 05:00 were considered to be phase delayed, while patients whose acrophase occurred prior to midnight were considered to be phase advanced.
Time Frame
Average 4 days (patients followed to hospital discharge)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adults undergoing mechanical ventilation in the medical intensive care unit.
Exclusion Criteria:
Central nervous system disease (stroke, seizure, dementia, etc)
Metabolic or hypoxic encephalopathy
Confirmed or suspected drug overdose
Currently receiving neuromuscular blockers
Coma
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Brian K Gehlbach, MD
Organizational Affiliation
University of Chicago
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jesse Hall, MD
Organizational Affiliation
University of Chicago
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Chicago
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60637
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
As this is a pilot study, there are no plans to share IPD.
Learn more about this trial
Sleep and Circadian Rhythms in Mechanically Ventilated Patients
We'll reach out to this number within 24 hrs